Report expects drugmakers' profits to grow under ACA

05/28/2013 | Forbes

An analysis from GlobalData projects that the drug industry will earn additional profits of $10 billion to $35 billion in the next 10 years as coverage increases under the Affordable Care Act and despite new regulations and expiring patents on blockbuster medications. "The overall balance could be positive, thanks to an additional 32 million formerly uninsured citizens becoming potential customers, resulting in up to $115 billion of new business," GlobalData's Joshua Owide said.

View Full Article in:

Forbes

Published in Brief: